financial press release: Halt Medical, Inc. Calif., Feb. 11, 2012 (uterine fibroid technology) + link to clinical trial Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, February 11, 2012

financial press release: Halt Medical, Inc. Calif., Feb. 11, 2012 (uterine fibroid technology) + link to clinical trial



Blogger's Note: uterine fibroids affects many women worldwide and can be the cause of a misdiagnosis in ovarian cancer (benign/malignancy); so of interest generally to women




About Halt Medical, Inc.
Founded in 2004, Halt Medical is a medical device company focused on women's health. The company has developed a procedure and related equipment for treating uterine fibroids that is less expensive, more effective and less invasive than other alternatives - the Halt GFA System. In June 2010, the U.S. Food and Drug Administration cleared the Halt 2000GI™ Electrosurgical System for soft tissue ablation using radiofrequency energy. The results of Halt Medical's international studies have led to recent approvals for treating uterine fibroids in Canada and the European Union. The Halt System may be used for general surgical use in the U.S. The company recently completed a 137 patient IDE clinical trial at 11 sites in 3 countries to demonstrate clinical safety and efficacy in the treatment of symptomatic uterine fibroids. FDA clearance is expected this year. The Company is located in Livermore, CA.
Information about the Halt Fibroid Study and a list of clinical sites in the U.S. may be found at www.clinicaltrials.gov, study number NCT00874029.


0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.